Addition versus multiplication

When multiple types of treatment-related tumors are observed, the UCR is defined as the sum of the slopes (of tumor incidence versus dose) for each tumor type. This is based on the worst-case assumption that tumors arising at multiple sites may be independent of each other, so that their risks are additive. When multiple doses are tested, the default approach is to consider each tumor type separately and to use the lowest dose at which a statistically significant increase in tumor incidence (compared to controls) is identified to calculate the slope for that tumor type. An example is shown in Table 7.3 ... 

A new technique for a determination of spin-multiplicities is the CIDNP-method. From emission signals in the nmr-spectrum a singlet or triplet state is deduced in insertion or addition reactions. This technique has been applied recently to 3a and 3g CIDNP-measurements in cyclohexane or CCI4 demonstrate that 3a reacts as singlet whereas 3g (di-f-butyl-derivative) involves a triplet intermediate. The latter experiment is in contrast with the results of stereo-specific addition of 3g to cis- or trans-huiene However the faster rate of addition versus insertion is thought to be responsible for this descrepancy... 

A fifth spectrophotometric method for the quantitative determination of the concentration of Pb + in blood uses a multiple-point standard addition based on equation 5.6. The original blood sample has a volume of 1.00 mb, and the standard used for spiking the sample has a concentration of 1560 ppb Pb +. All samples were diluted to 5.00 mb before measuring the signal. A calibration curve of Sjpike versus Vj is described by... 

Additional objectives of clinical trials conducted in Phase II may include evaluation of potential study endpoints, therapeutic regimens (including concomitant medications) and target populations (e.g., mild versus severe disease) for further study in Phase II or III. These objectives may be served by exploratory analyses, examining subsets of data and by including multiple endpoints in trials. 

Identification of the P450 form(s) responsible for the metabolism of a xenobiotic can be achieved by correlation of the rates of metabolism of the new entity with the rates of metabolism for marker substrates for specific enzymes in different liver specimens with the levels of the different P450 forms (for review see Wrighton et al., 1993b). A typical approach involves the selection of multiple human tissue preparations with high , medium and low levels of the enzymes of interest. The rate of metabolism of the new entity is assessed in these samples and correlation analyses are performed versus the different marker activities. The enzyme with the highest correlation with the metabolism of the new entity is likely to be the principal enzyme involved in its metabolism. Alternatively, or in addition to correlation analyses, the roles of specific enzymes can be analysed by selective immunoinhibition or chemical inhibition of different P450 forms. The use of chemical inhibitors has been reviewed recently (Halpert et al.,... 

---